Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for colorectal cancer, susceptibility to, 8 has been reported in the published literature.
No clinical trials have been registered for colorectal cancer, susceptibility to, 8.
168 publications have been identified in PubMed for colorectal cancer, susceptibility to, 8. Kisho has analyzed 118 by research type. Research spans Epidemiology / Natural History (37%), Basic Science / Preclinical (30%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 44 | 37% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:42 PM UTC
Online Mendelian Inheritance in Man
Common questions about colorectal cancer, susceptibility to, 8
Laboratory research |
35 |
30% |
Research summaries | 23 | 19% |
Testing and diagnosis research | 9 | 8% |
Clinical study results | 3 | 3% |
Patient case studies | 2 | 2% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Zhao F (2026). [PMID: 41808042](https://pubmed.ncbi.nlm.nih.gov/41808042/). *BMC Cancer*. [Basic Science / Preclinical]
Huang YC (2026). [PMID: 40780402](https://pubmed.ncbi.nlm.nih.gov/40780402/). *Clin Gastroenterol Hepatol*. [Basic Science / Preclinical]
Ferreira FO (2026). [PMID: 42088596](https://pubmed.ncbi.nlm.nih.gov/42088596/). *Lancet Reg Health Am*. [Epidemiology / Natural History]
Chuong M (2026). [PMID: 41559068](https://pubmed.ncbi.nlm.nih.gov/41559068/). *Nat Commun*. [Review / Meta-Analysis]
Vermani L (2026). [PMID: 41898618](https://pubmed.ncbi.nlm.nih.gov/41898618/). *Int J Mol Sci*. [Basic Science / Preclinical]
Campoy S (2026). [PMID: 41389835](https://pubmed.ncbi.nlm.nih.gov/41389835/). *J Natl Cancer Inst*. [Review / Meta-Analysis]
Helfand BT (2026). [PMID: 42053416](https://pubmed.ncbi.nlm.nih.gov/42053416/). *Prostate*. [Epidemiology / Natural History]
Xie H (2026). [PMID: 41731847](https://pubmed.ncbi.nlm.nih.gov/41731847/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Yan G (2026). [PMID: 41247883](https://pubmed.ncbi.nlm.nih.gov/41247883/). *Int J Surg*. [Basic Science / Preclinical]
Peoples AR (2026). [PMID: 41645200](https://pubmed.ncbi.nlm.nih.gov/41645200/). *BMC Med*. [Epidemiology / Natural History]